Bashir Hamidu Rukaiya, Chalikonda Divya M, Hann Hie-Won
Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Vaccines (Basel). 2021 Jul 30;9(8):838. doi: 10.3390/vaccines9080838.
Chronic hepatitis B virus (HBV) infection is one of the most common causes of hepatocellular carcinoma (HCC), a malignant tumor with high mortality worldwide. One remarkable clinical feature of HBV-related HCC is that the risk of development is higher in males and postmenopausal females compared to other females. Increasing evidence also indicates that the prognosis of HBV-associated HCC may involve gender disparity, with females having more favorable outcomes. The proposed mechanism of this gender disparity is thought to be complex and multifactorial. Attributions have been made to gender differences in behavioral risk factors, host stress, immune response, psychology, metabolic risk factors, tumor biology, and hormonal factors. Gender disparities in hormonal factors and stress with consequent incited inflammation and hepatocarcinogenesis in HBV-related HCC is a particularly burgeoning area of investigation. Clarifying these mechanisms could provide insight into HBV-related HCC pathogenesis, and potentially provide a target for prevention and treatment of this disease. Reported herein is a case series involving two families affected by vertically transmitted chronic hepatitis B, longitudinally observed over multiple decades, with family members demonstrating discordant outcomes related to HCC, with worse outcomes among affected males. As a supplement to this case, we review the currently available literature on gender differences in outcomes from HBV-related HCC. In reporting this case series, we aim to add our important observation to the current literature and highlight the need for further research in the mechanisms involved in gender disparity in the prognosis of HBV-related HCC.
慢性乙型肝炎病毒(HBV)感染是肝细胞癌(HCC)最常见的病因之一,HCC是一种全球死亡率很高的恶性肿瘤。HBV相关HCC的一个显著临床特征是,与其他女性相比,男性和绝经后女性发生HCC的风险更高。越来越多的证据还表明,HBV相关HCC的预后可能存在性别差异,女性的预后更有利。这种性别差异的潜在机制被认为是复杂的且多因素的。其归因包括行为风险因素、宿主应激、免疫反应、心理、代谢风险因素、肿瘤生物学和激素因素等方面的性别差异。激素因素和应激导致的性别差异,进而引发HBV相关HCC中的炎症和肝癌发生,是一个特别新兴的研究领域。阐明这些机制可以深入了解HBV相关HCC的发病机制,并有可能为该疾病的预防和治疗提供靶点。本文报道了一个病例系列,涉及两个受垂直传播的慢性乙型肝炎影响的家庭,经过数十年的纵向观察,家庭成员在HCC相关结局上表现出不一致,受影响的男性结局更差。作为该病例的补充,我们回顾了目前关于HBV相关HCC结局性别差异的现有文献。在报道这个病例系列时,我们旨在将我们的重要观察结果补充到当前文献中,并强调需要进一步研究HBV相关HCC预后中性别差异所涉及的机制。